Aldeyra Therapeutics (137.MU) Q3 2026 Earnings

31JulConfirmed
Q2 2026
Next
-0.08
-0.07
-0.06
-0.05

Details

Expected EPS
-0.07627216002
Actual EPS
N/A
Surprise EPS
0.08
Surprise Percent
+100%

Description

Aldeyra Therapeutics (137.MU) will report earnings of for Q3 2026 on July 31, 2026.

0 Comments

Share your thoughts